Selected article for: "respiratory disease and SARS structure"
Author: Wu, Jun; Yuan, Xiaohui; Wang, Bing; Gu, Rui; Li, Wei; Xiang, Xuemei; Tang, Lijun; Sun, Hongyu
Title: Severe Acute Respiratory Syndrome Coronavirus 2: From Gene Structure to Pathogenic Mechanisms and Potential Therapy
  • Cord-id: rwslewy8
  • Document date: 2020_7_3
    • ID: rwslewy8
    Snippet: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a newly emerging respiratory virus with high morbidity, which was named coronavirus disease 2019 (COVID-19) by World Health Organization (WHO). COVID-19 has triggered a series of threats to global public health. Even worse, new cases of COVID-19 infection are still increasing rapidly. Therefore, it is imperative that various effective vaccines and drugs should be developed to prevent and treat COVID-19 and reduce the serious impact
    Document: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a newly emerging respiratory virus with high morbidity, which was named coronavirus disease 2019 (COVID-19) by World Health Organization (WHO). COVID-19 has triggered a series of threats to global public health. Even worse, new cases of COVID-19 infection are still increasing rapidly. Therefore, it is imperative that various effective vaccines and drugs should be developed to prevent and treat COVID-19 and reduce the serious impact on human beings. For this purpose, detailed information about the pathogenesis of COVID-19 at the cellular and molecular levels is urgently needed. In this review, we summarized the current understanding on gene structure, protein function, and pathogenic mechanisms of SARS-CoV-2. Based on the above, we refined the correlations among gene structure, protein function, and pathogenic mechanisms of SARS-CoV-2. Importantly, we further discussed potential therapeutic targets, aiming to accelerate the advanced design and development of vaccines and therapeutic drugs against COVID-19.

    Search related documents:
    Co phrase search for related documents
    • abnormal activation and adaptive immune response: 1
    • abnormal activation and liver cell: 1
    • abnormal immune response and acute kidney injury: 1
    • accessory protein and acute ards respiratory distress syndrome: 1
    • accessory protein and acute sars cov respiratory syndrome cov: 1, 2
    • ace inhibitor and acei ace inhibitor: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • ace inhibitor and acute ards respiratory distress syndrome: 1, 2, 3, 4
    • ace inhibitor and acute kidney injury: 1, 2, 3, 4
    • ace inhibitor and acute sars cov respiratory syndrome cov: 1
    • acute ards respiratory distress syndrome and adaptive immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • acute ards respiratory distress syndrome and ade antibody dependent enhancement: 1, 2
    • acute ards respiratory distress syndrome and liver cell: 1, 2
    • acute ards respiratory distress syndrome and liver dysfunction: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • acute kidney injury and adaptive immune response: 1, 2
    • acute kidney injury and liver dysfunction: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
    • acute sars cov respiratory syndrome cov and adaptive immune response: 1, 2, 3, 4, 5, 6, 7
    • acute sars cov respiratory syndrome cov and liver cell: 1
    • acute sars cov respiratory syndrome cov and liver dysfunction: 1, 2
    • adaptive immune response and ade antibody dependent enhancement: 1